Condition
Caffeine Dependence
Total Trials
4
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04560595Not ApplicableCompletedPrimary
Remote Guided Caffeine Reduction
NCT05526170Active Not Recruiting
Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring
NCT05323578Completed
Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists
NCT03731286Not ApplicableCompletedPrimary
A Long-term Safety and Efficacy of EnXtra (E-AG-01) in Healthy Adults
Showing all 4 trials